These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 26305029)
1. Endometrial polyps: when to resect? de Azevedo JM; de Azevedo LM; Freitas F; Wender MC Arch Gynecol Obstet; 2016 Mar; 293(3):639-43. PubMed ID: 26305029 [TBL] [Abstract][Full Text] [Related]
2. Opportunities and risk factors for premalignant and malignant transformation of endometrial polyps: management strategies. Wang JH; Zhao J; Lin J J Minim Invasive Gynecol; 2010; 17(1):53-8. PubMed ID: 20129333 [TBL] [Abstract][Full Text] [Related]
3. Hysterscopic Resection of Premalignant and Malignant Endometrial Polyps: Is it a Safe Alternative to Hysterectomy? Elyashiv O; Sagiv R; Kerner R; Keidar R; Menczer J; Levy T J Minim Invasive Gynecol; 2017; 24(7):1200-1203. PubMed ID: 28802955 [TBL] [Abstract][Full Text] [Related]
6. How often are endometrial polyps malignant in asymptomatic postmenopausal women? A multicenter study. Ferrazzi E; Zupi E; Leone FP; Savelli L; Omodei U; Moscarini M; Barbieri M; Cammareri G; Capobianco G; Cicinelli E; Coccia ME; Donarini G; Fiore S; Litta P; Sideri M; Solima E; Spazzini D; Testa AC; Vignali M Am J Obstet Gynecol; 2009 Mar; 200(3):235.e1-6. PubMed ID: 19027096 [TBL] [Abstract][Full Text] [Related]
7. Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy. Lenci MA; Nascimento VA; Grandini AB; Fahmy WM; Depes Dde B; Baracat FF; Lopes RG Einstein (Sao Paulo); 2014; 12(1):16-21. PubMed ID: 24728240 [TBL] [Abstract][Full Text] [Related]
8. The risk factors for premalignant and malignant endometrial polyps in premenopausal and postmenopausal women and trends over the past decade: A retrospective study in a single center, South Korea. Jang S; Hwang SO Eur J Obstet Gynecol Reprod Biol; 2024 Apr; 295():118-123. PubMed ID: 38354603 [TBL] [Abstract][Full Text] [Related]
9. The risk of malignancy in uterine polyps: A systematic review and meta-analysis. Uglietti A; Buggio L; Farella M; Chiaffarino F; Dridi D; Vercellini P; Parazzini F Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():48-56. PubMed ID: 31009859 [TBL] [Abstract][Full Text] [Related]
10. Polycystic ovary syndrome is associated with a higher risk of premalignant and malignant endometrial polyps in premenopausal women: a retrospective study in a tertiary teaching hospital. Lu L; Luo J; Deng J; Huang C; Li C BMC Womens Health; 2023 Mar; 23(1):127. PubMed ID: 36964546 [TBL] [Abstract][Full Text] [Related]
11. Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy. Antunes A; Costa-Paiva L; Arthuso M; Costa JV; Pinto-Neto AM Maturitas; 2007 Aug; 57(4):415-21. PubMed ID: 17587515 [TBL] [Abstract][Full Text] [Related]
12. HISTOPATHOLOGIC FINDINGS IN WOMEN UNDERGOING HYSTEROSCOPIC RESECTION OF ENDOMETRIAL POLYPS AND UTERINE MYOMAS. Soljačić Vraneš H; Djaković I; Vrljičak M; Đurić Orsag N; Kuna K; Kraljević Z; Leniček T; Brlečić I Acta Clin Croat; 2019 Dec; 58(4):627-631. PubMed ID: 32595247 [TBL] [Abstract][Full Text] [Related]
13. Suspecting malignancy in endometrial polyps: value of hysteroscopy. Daniele A; Ferrero A; Maggiorotto F; Perrini G; Volpi E; Sismondi P Tumori; 2013; 99(2):204-9. PubMed ID: 23748815 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of endometrial abnormalities: an observational study on 1020 women undergoing hysteroscopic surgery. Patrizi L; Ticconi C; Borelli B; Finocchiaro S; Chiaramonte C; Sesti F; Mauriello A; Exacoustos C; Casadei L BMC Womens Health; 2022 Apr; 22(1):106. PubMed ID: 35392892 [TBL] [Abstract][Full Text] [Related]
15. Risk of malignancy on suspicion of polyps in menopausal women. Bel S; Billard C; Godet J; Viviani V; Akladios C; Host A; Faller E; Boisrame T; Hummel M; Baldauf JJ; Lecointre L; Garbin O Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():138-142. PubMed ID: 28763739 [TBL] [Abstract][Full Text] [Related]
16. Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis. Sasaki LMP; Andrade KRC; Figueiredo ACMG; Wanderley MDS; Pereira MG J Minim Invasive Gynecol; 2018; 25(5):777-785. PubMed ID: 29454147 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors for malignancy in hysteroscopy-resected endometrial polyps. Wong CLH; So PL Int J Gynaecol Obstet; 2021 Dec; 155(3):433-441. PubMed ID: 33621356 [TBL] [Abstract][Full Text] [Related]
18. Prediction of Premalignant and Malignant Endometrial Polyps by Clinical and Hysteroscopic Features. Shor S; Pansky M; Maymon R; Vaknin Z; Smorgick N J Minim Invasive Gynecol; 2019; 26(7):1311-1315. PubMed ID: 30611972 [TBL] [Abstract][Full Text] [Related]
19. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Savelli L; De Iaco P; Santini D; Rosati F; Ghi T; Pignotti E; Bovicelli L Am J Obstet Gynecol; 2003 Apr; 188(4):927-31. PubMed ID: 12712087 [TBL] [Abstract][Full Text] [Related]
20. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Costa-Paiva L; Godoy CE; Antunes A; Caseiro JD; Arthuso M; Pinto-Neto AM Menopause; 2011 Dec; 18(12):1278-82. PubMed ID: 21926931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]